Posted on 15-11-2018

Camel-IDS, laureate of the Fournier-Majoie Foundation in 2015, achieves a capital increase of 37 million euros.

The startup Camel-IDS, a spin-off of the Vrije Universiteit Brussel (VUB), achieved successfully a major capital increase of 37 million euros, which will allow the company to conduct clinical studies for some of its programmes of targeted radioimmunotherapy against several types of cancer.

Camel-IDS, laureate of the Fournier-Majoie Foundation since 2015, has benefited from successive financial supports and from a constant operational guidance.

Download the complete press release here.